Thursday, March 31, 2011 12:13:14 AM
Recent NVAX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2024 09:08:57 PM
- Novavax to Participate in Jefferies London Healthcare Conference • PR Newswire (US) • 11/13/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:08:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 04:21:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 01:04:48 PM
- Novavax Reports Third Quarter 2024 Financial Results and Operational Highlights • PR Newswire (US) • 11/12/2024 01:02:00 PM
- U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial • PR Newswire (US) • 11/11/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2024 10:01:06 PM
- Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024 • PR Newswire (US) • 11/04/2024 09:30:00 PM
- Åsa Manelius Named Managing Director of Novavax AB Site • PR Newswire (US) • 11/04/2024 11:00:00 AM
- Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial • PR Newswire (US) • 10/16/2024 12:14:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 12:00:11 PM
- Novavax's Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Receives Authorization in the EU • PR Newswire (US) • 10/09/2024 11:00:00 AM
- Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development • PR Newswire (US) • 09/25/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/18/2024 08:08:16 PM
- Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S. • PR Newswire (US) • 09/13/2024 01:25:00 PM
- Novavax to Participate in Upcoming September Conferences • PR Newswire (US) • 09/04/2024 01:25:00 PM
- Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. • PR Newswire (US) • 08/30/2024 08:19:00 PM
- Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. • PR Newswire (US) • 08/30/2024 07:46:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 08:47:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 09:06:20 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/08/2024 08:15:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:04:56 PM
- Novavax Reports Second Quarter 2024 Financial Results and Operational Highlights • PR Newswire (US) • 08/08/2024 12:02:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:37:07 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM